Then, we simulated the inhibitory effect of PRMT5/MTA inhibitor on GBMs by in vitro and in vivo experiments in which MTAP‐deficient glioma cells coexisted with microglia and neurons with normal MTAP expression. Here, PRMT5 is linked to glioma.